Skip to main content
Top

Arthritis Research & Therapy

Issue Special Issue 2/2012

Proceedings of Osteorheumatology 2011: International Congress on Bone Involvement in Arthritis

Content (19 Articles)

Open Access Introduction

Osteo-Rheumatology: a new discipline?

Gerolamo Bianchi, Luigi Sinigaglia

Open Access Meeting abstract

Long-term osteoporosis treatment: myth or reality?

Andrea Giusti

Open Access Meeting abstract

Clinical significance of bone changes in osteoarthritis

Tuhina Neogi

Open Access Meeting abstract

IL-1 inhibition in autoinflammatory diseases

Alberto Martini

Open Access Meeting abstract

Chondrogenesis, joint formation, and cartilage metabolism

Mary B Goldring

Open Access Meeting abstract

Subchondral bone remodelling and osteoarthritis

Jorge A Román-Blas, Santos Castañeda, Raquel Largo, Gabriel Herrero-Beaumont

Open Access Meeting abstract

The model of erosive hand osteoarthritis

Margreet Kloppenburg

Open Access Meeting abstract

Damage progression in rheumatoid arthritis: the role of biologic agents

Ennio Giulio Favalli

Open Access Meeting abstract

Viscosupplementation in the treatment of osteoarthritis

Alberto Migliore, Francesca Giovannangeli

Open Access Meeting abstract

Combination and sequential treatments in the management of osteoporosis

Socrates Papapoulos

Open Access Meeting abstract

Long-term efficacy and safety of biologics in rheumatoid arthritis

Carlomaurizio Montecucco

Open Access Meeting abstract

Biologicals and bone loss

Willem F Lems

Open Access Meeting abstract

The role of bone morphogenetic proteins in ankylosing spondylitis

Rik J Lories

Open Access Meeting abstract

Epidemiology of osteoporosis and fractures in ankylosing spondylitis

Philip N Sambrook

Open Access Meeting abstract

Imaging of ankylosing spondylitis

Mikkel Østergaard

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine